Lymphoid Enhancer-Binding Factor 1
"Lymphoid Enhancer-Binding Factor 1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A T-cell factor that plays an essential role in EMBRYONIC DEVELOPMENT.
Descriptor ID |
D051821
|
MeSH Number(s) |
D12.776.260.730.500 D12.776.660.235.400.800.500 D12.776.664.235.400.800.500 D12.776.930.875.500
|
Concept/Terms |
Lymphoid Enhancer-Binding Factor 1- Lymphoid Enhancer-Binding Factor 1
- Lymphoid Enhancer Binding Factor 1
- LEF-1 Transcription Factor
- LEF 1 Transcription Factor
- Transcription Factor, LEF-1
- T Cell-Specific Transcription Factor 1-alpha
- T Cell Specific Transcription Factor 1 alpha
|
Below are MeSH descriptors whose meaning is more general than "Lymphoid Enhancer-Binding Factor 1".
Below are MeSH descriptors whose meaning is more specific than "Lymphoid Enhancer-Binding Factor 1".
This graph shows the total number of publications written about "Lymphoid Enhancer-Binding Factor 1" by people in this website by year, and whether "Lymphoid Enhancer-Binding Factor 1" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 1 | 0 | 1 |
2017 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Lymphoid Enhancer-Binding Factor 1" by people in Profiles.
-
Diagnostic Utility of Lymphoid Enhancer Binding Factor 1 Immunohistochemistry in Small B-Cell Lymphomas. Am J Clin Pathol. 2017 Mar 01; 147(3):292-300.
-
Role of miR-34a-5p in Hematopoietic Progenitor Cells Proliferation and Fate Decision: Novel Insights into the Pathogenesis of Primary Myelofibrosis. Int J Mol Sci. 2017 Jan 13; 18(1).
-
The TCF-1 and LEF-1 transcription factors have cooperative and opposing roles in T cell development and malignancy. Immunity. 2012 Nov 16; 37(5):813-26.